Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19.
read more
Tuesday, September 05, 2017
SGS has consolidating its consultancy portfolio into a single, comprehensive offering.
read more
Friday, December 04, 2020
Catalent has entered into a commercial supply agreement with Blueprint Medicines following FDA approval of GAVRETO.
read more
Wednesday, February 10, 2021
Catalent hadssigned an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
read more
Tuesday, October 13, 2026
Catalent has signed a commercial supply agreement with consumer health company Mantra to develop, manufacture and package single-serve oral gels for over-the-counter use. The agreement covers products for occasional sleeplessness, pain relief and ...
read more
Catalent welcomed the news from Nocion Therapeutics that its first patient has been dosed with NOC-100, an inhaled formula of its NTX-1175 small molecule candidate.
read more
Monday, November 02, 2020
Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support.
read more
Tuesday, September 19, 2017
Catalent has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services.
read more
Friday, February 26, 2021
Catalent and Delphi Genetics have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics.
read more
Wednesday, January 13, 2021
Catalent has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics.
read more
Wednesday, February 05, 2020
Catalent has agreed to acquire MaSTherCell Global for an aggregate of $315 million in cash, subject to a customary adjustments.
read more
Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
read more
Wednesday, September 14, 2016
Catalent has announced an agreement for Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, Inc., to acquire Pharmatek Laboratories, Inc., a West Coast, U.S.-based specialist in drug development and clinical manufacturing.
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has reached an agreement to acquire ...
read more
Friday, September 11, 2020
Catalent is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Maryland.
read more